The care of patients with diabetic nephropathy: Audit, feedback, and improvement

QJM: An International Journal of Medicine

Volumn 92, Issue 8, 1999, Pages 443-449

  Dunn, E J ^a   Burton, C J ^a   Feest, T G ^a  

^a SOUTHMEAD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGE; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY FAILURE; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE DURATION; FEEDBACK SYSTEM; FEMALE; HEALTH CARE QUALITY; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; MEDICAL EDUCATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT CARE; PATIENT REFERRAL; PRESCRIPTION; PRIORITY JOURNAL; SECONDARY HYPERPARATHYROIDISM;

EID: 0032859913     PISSN: 00335622     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/92.8.443     Document Type: Article

References (29)

1. United States Renal Data System. USRDS 1997 Annual Data Report. Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, April 1997.
2. Lippert J, Ritz E, Schwarzbeck A, Schneider P. The rising tide of ESRF from diabetic nephropathy type II - and epidemiological analysis. Nephrol Dial Transplant 1995; 10:462-7.
3. Roderick PJ, Ferris G, Feest TG. The provision of renal replacement therapy for adults in England and Wales: recent trends and future directions. Q J Med 1998; 91:581-7.
4. Marcelli D, Spotti D, Conte F, Limido A, Malberti F, Locatelli F. Prognosis of diabetic patients on dialysis: analysis of Lombardy Registry data. Nephrol Dial Transplant 1995; 10:1895-901.
5. Hasslacher C, Ritz E, Wahl P, Michael C. Similar risks of nephropathy in patients with Type I or Type II Diabetes Mellitus. Nephrol Dial Transplant 1989; 4:859-63.
6. Biesenbach G, Janko O, Zazgornik J. Similar rate of progression in the predialysis phase of Type I and Type II Diabetes Mellitus. Nephrol Dial Transplant 1994; 9:1097-102.
7. Parving HH, Jacobsen P, Rossing K, Smidt UM, Hommel E, Rossing P. Benefits of long term antihypertensive treatment on the prognosis in Diabetic Nephropathy. Kidney Int 1996; 49:1779-82.
8. Bjorck S, Nyberg G, Mulec H, Granerus G, Herlitz H, Aurell M. Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy. Br Med J 1986; 293:471-4.
9. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin converting enzyme inhibitors on diabetic nephropathy. N Engl J Med 1993; 329:1456-62.
10. Bakris GL, Copley JB, Vicknair N, Sadler R, Leurgons S. Calcium channel blockers versus other antihypertensive therapies on the progression of NIDDM associated nephropathy. Kidney Int 1996; 50:1641-50.
11. Kasiske BL, Lakatua JD, Ma JZ, Louis TA. A meta-analysis of the effects of dietary protein restriction on the rate of decline in renal function. Am J Kidney Dis 1998; 31:954-61.
12. Pedrini MT, Levey AS, Lau J, Chalmers TC, Wang PH. The effect of dietary protein restriction on the progression of diabetic and non-diabetic renal diseases: a meta-analysis. Ann Intern Med 1996; 124:627-32.
13. Krolewski AS, Warram JH, Christlieb AR. Hypercholesterolaemia - A determinant of renal function loss and deaths in IDDM and nephropathy. Kidney Int 1994; 45:s125-s131.
14. Diabetes Mellitus in Europe: a problem at all ages in all Countries. A model for prevention and self care. Ital Diabetol 1990; 10(Suppl.).
15. Krans HMJ, Porta M, Keen H, eds. Guidelines for the prevention of renal failure. In: Diabetes care and research in Europe: the St Vincent Declaration action programme. WHO Regional Office for Europe, 1992:29-32.
16. British National Formulary. British Medical Association and Royal Pharmaceutical Society of Great Britain, 1998 (Number 35 March).
17. American Diabetes Association. American Diabetes Association consensus statement: role of cardiovascular risk factors in prevention and treatment of microvascular disease in diabetes. Diabetes Care 1989; 12:573-9.
18. Oliver MF, Pyorala K, Shepherd J. Management of hyperlipidaemia. Eur Heart J 1997; 18:371-5.
19. The Renal Association. Treatment of adult patients with renal failure: recommended standards and audit measures. London, Publications Unit of the Royal College of Physicians, 1995.
20. Yokoyama H, Tomonaga P, Hirayama M, Ishii A, Takeda M, Babazano T, et al. Predictors of the progression of diabetic nephropathy and the beneficial effect of angiotensin converting enzyme inhibitors in NIDDM patients. Diabetologia 1997; 40:405-11.
21. Breyer JA, Bain RP, Evans JK, Nahman NS, Lewis EJ, Cooper M, et al. The Collaborative Study Group. Predictors of progression of renal insufficiency in patients with insulin dependent diabetes and overt diabetic nephropathy. Kidney Int 1996; 50:1651-8.
22. Kostis JB, Davis BR, Cutler J, Grimm RH Jr, Berge KG, Cohen JD, et al. Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. SHEP Cooperative Research Group. JAMA 1997; 278:212-21.
23. Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 1998; 351:1755-62.
24. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors and 12 year cardiovascular mortality in multiple risk factor intervention trial. Diabetes Care 1993; 16:434-44.
25. Shepherd J, Cobbe SM, Ford I. Prevention of Coronary heart disease with pravastatin in men with hypercholesterolaemia. N Engl J Med 1995; 333:1301-7.
26. Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Survival Study (4S). Lancet 1994; 344:1383-9.
27. Pyorala K, De Baker G, Graham I, Poole-Wilson P, Wood D. Prevention of coronary heart disease in clinical practice. Recommendations of the task force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. Eur Heart J 1994; 15:1300-31.
28. Jungers P, Zingraff J, Albouze G, Chauveau P, Page T, Hannedouche T, et al. Late referral to maintenance dialysis: detrimental consequences. Nephrol Dial Transplant 1993; 8:1089-93.
29. Pommer W, Bressel F, Chen F, Molzahn M. There is room for improvement of preterminal care in diabetic patients with ESRF - The epidemiological evidence in Germany. Nephrol Dial Transplant 1997; 12:1318-31.